Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target.

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Tuberculosis (TB) remains a global health emergency, exacerbated by multi- and extensively-drug resistant Mycobacterium tuberculosis (Mtb) strains.
• The Mtb cell wall is a critical target for anti-TB chemotherapy due to its essential role in bacterial survival and antibiotic resistance.

Purpose of the Study:

• To review the biosynthesis of key Mtb cell wall components.
• To highlight the mechanisms of action for current anti-TB drugs targeting the cell wall.
• To identify novel enzyme targets for future anti-TB drug development.

Main Methods:

• Literature review of mycobacterial cell wall biosynthesis pathways.
• Analysis of existing anti-TB drug mechanisms.
• Identification and evaluation of potential novel drug targets within Mtb cell wall synthesis.

Main Results:

• The Mtb cell wall comprises peptidoglycan, arabinogalactan, and mycolic acid layers, crucial for Mtb growth and virulence.
• Existing anti-TB drugs primarily inhibit enzymes involved in cell wall component biosynthesis.
• Several unexploited enzymes in Mtb cell wall assembly present promising targets for new therapeutic strategies.

Conclusions:

• The Mtb cell wall is a validated and vital target for anti-TB drug development.
• Understanding Mtb cell wall biosynthesis is key to overcoming drug resistance.
• Targeting novel enzymes in cell wall synthesis offers a promising avenue for developing next-generation anti-TB agents.